Measurement of serum levels of natalizumab, an immunoglobulin G4 therapeutic monoclonal antibody
- 1 April 2011
- journal article
- Published by Elsevier BV in Analytical Biochemistry
- Vol. 411 (2), 271-276
- https://doi.org/10.1016/j.ab.2011.01.001
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Strategies and challenges for the next generation of therapeutic antibodiesNature Reviews Immunology, 2010
- Fab-arm exchangeNature Biotechnology, 2010
- A Novel Heterophilic Antibody Interaction Involves IgG4Scandinavian Journal of Immunology, 2010
- Impact of Molecular Processing in the Hinge Region of Therapeutic IgG4 Antibodies on Disposition Profiles in Cynomolgus MonkeysDrug Metabolism and Disposition, 2009
- Therapeutic IgG4 antibodies engage in Fab-arm exchange with endogenous human IgG4 in vivoNature Biotechnology, 2009
- Clinical response, pharmacokinetics, development of human anti-chimaeric antibodies, and synovial tissue response to rituximab treatment in patients with rheumatoid arthritisAnnals Of The Rheumatic Diseases, 2009
- Human IgG4 Binds to IgG4 and Conformationally Altered IgG1 via Fc-Fc InteractionsThe Journal of Immunology, 2009
- A Novel Immunoglobulin-Immunoglobulin Interaction in AutoimmunityPLOS ONE, 2008
- Isotype selection in antibody engineeringNature Biotechnology, 2007
- The Apparent Monovalency of Human IgG4 Is Due to BispecificityInternational Archives of Allergy and Immunology, 1999